Obestatin, derived from the ghrelin precursor, modulates hypothalamic appetite (NPY/AgRP), growth hormone (GHRH/somatostatin), and reproductive (GnRH/LH/FSH) axes with significant species-dependent variation between rodents and sheep.
Three axes, species-dependentObestatin modulates appetite, growth hormone, and reproductive axes but with dramatically different effects between rodents and sheep—a complexity that has hindered its study
What the researchers found
Appetite: inconsistent in rodents, significant orexigenic gene changes in sheep. GH axis: no effect in rodents, ↑GHRH/somatostatin mRNA, ↑GH synthesis/secretion in sheep. Reproductive: present in Leydig/pituitary cells, modulates GnRH/LH/FSH in vitro. Species variation is major.
Why it matters
Despite sharing a precursor with ghrelin (one of the most studied gut peptides), obestatin remains poorly understood. Clarifying its roles could reveal new therapeutic targets in appetite, growth, and reproductive disorders.
How the study worked
Narrative review synthesizing animal studies on obestatin's central neuroendocrine effects across species (rodents and sheep).
What this study cannot tell us
Review of inconsistent data across species. No clinical human studies. Obestatin's receptor remains debated. Functional relevance in humans unknown.
How to read the evidence
Narrative review of inconsistent preclinical data. Highlights knowledge gaps rather than established findings.
When this study was published
Published in 2025.
The bigger picture
Obestatin may represent an untapped therapeutic target from the ghrelin system. Its species-dependent effects suggest it plays a fine-tuning role that varies with physiological context—potentially useful for personalized medicine.
Questions still open
- Is obestatin clinically relevant in humans?
- Could obestatin modulation complement ghrelin-targeting therapies?
- Why do obestatin effects differ so dramatically between species?
Common questions
What is obestatin?
Could obestatin be used as a medicine?
Read the original research
The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic-Pituitary Axes.
International journal of molecular sciences, 26(15)
Citation
Szlis, Michał; Wójcik-Gładysz, Anna; Gajewska, Alina; Przybyl, Bartosz Jaroslaw. (2025). The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic-Pituitary Axes.. International journal of molecular sciences, 26(15). https://doi.org/10.3390/ijms26157395